The short answer
Copper tripeptide-1 is the INCI name for GHK-Cu, the standardised nomenclature used to declare ingredients on cosmetic labels. It is the same molecule under a different naming system, but the framework regulating it as a cosmetic ingredient is entirely separate from medicines regulation.
Key facts
- INCI name
- Copper tripeptide-1
- Same as
- GHK-Cu
- Naming system
- International Nomenclature of Cosmetic Ingredients
- Framework
- Cosmetics regulation, not medicines
- Implies
- Permitted in cosmetic products
- Does not imply
- Medicinal approval of any kind
What INCI is for
The International Nomenclature of Cosmetic Ingredients gives every cosmetic ingredient one standardised name so that labels are comparable across products and jurisdictions. It is a naming convention with a regulatory function (allowing consumers and regulators to identify what is in a product) and nothing more.
Why the same molecule has two names
Chemistry, medicine and cosmetics each maintain their own nomenclature. The same substance is glycyl-L-histidyl-L-lysine copper to a chemist, prezatide in generic drug naming, and copper tripeptide-1 on a cosmetic label. None of these is more correct than the others; they belong to different systems built for different purposes.
Research material referenced
GHK-Cu 100mg, third-party HPLC tested
The distinction that actually matters
Cosmetics and medicines are regulated under separate frameworks with different requirements. A cosmetic is regulated on safety and on the claims it makes about appearance; a medicine requires demonstrated efficacy and safety for a therapeutic claim, assessed by a regulator. An ingredient being permitted in cosmetics says nothing whatsoever about medicinal approval, and the two should never be conflated.
Why this matters for research material
The existence of copper tripeptide-1 in cosmetic products creates a tempting but false inference: that GHK-Cu is therefore an approved or established substance. It is approved as a cosmetic ingredient. Material supplied for laboratory research is neither a cosmetic product nor a medicine, and its status is unaffected by cosmetic regulation.
The claims difference
A cosmetic may make appearance claims within defined limits. It may not claim to treat, cure or prevent anything; the moment it does, it is making a medicinal claim and falls under a different framework. That boundary is the same one governing research material, which is why this library describes mechanisms and studies rather than outcomes.
Frequently asked questions
Does cosmetic use mean GHK-Cu is approved?
As a cosmetic ingredient, within that framework. It carries no implication of medicinal approval, which is assessed entirely separately.
Can a cosmetic claim to repair skin?
Not therapeutically. Cosmetics may make appearance claims; treating, curing or preventing anything is a medicinal claim under a different framework.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubChemPubChem · GHK-Cu copper complex (CID 71587328)pubchem.ncbi.nlm.nih.gov
- RefMHRA: Medicines and Healthcare products Regulatory Agencygov.uk
- PubMedPickart L & Margolina A, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int 2015 (PMID 26236730)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L et al., The Effect of the Human Peptide GHK on Gene Expression. Brain Sci 2017 (PMID 28212278)pubmed.ncbi.nlm.nih.gov
- PubMedPickart L, The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed 2008 (PMID 18644225)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Glycyl-L-histidyl-L-lysine (CID 73587)pubchem.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More GHK-Cu (Copper Peptide) articles
- Research GHK-Cu and Cosmetic Copper Peptides ComparedCosmetic copper peptide products contain copper tripeptide-1 under cosmetics regulation. Research material is unformulated and sits under no such framework.
- Copper Peptides: What the Term CoversCopper peptide describes any peptide that binds copper, not one compound. What unites the class, and why GHK-Cu is the most studied member.
- Loren Pickart and the GHK Research ProgrammePickart isolated GHK in 1973 and has authored much of its literature since. What that concentration of authorship means for reading the evidence.
- GHK-Cu in Skin ResearchMost GHK-Cu skin work is in vitro or in animal models. What the studies measured, what the model systems can support, and where the claims outrun them.
- GHK-Cu in the Published LiteratureWhat the GHK-Cu literature actually contains: matrix biosynthesis, antioxidant activity via copper delivery, gene expression, and where the gaps are.